| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10052222 | The Journal of Urology | 2005 | 6 Pages |
Abstract
High viability, good dispersion and efficient binding to tumor cells by BCG bacilli in the Tokyo172 preparation seem to be the main reasons for the lower clinical dose of this preparation compared with the Connaught preparation (18 vs 81 mg dry weight).
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
NORIKO IKEDA, IKURO HONDA, IKUYA YANO, AKIRA KOYAMA, ICHIRO TOIDA,